Citations 1
Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): Data from Southwest Oncology Group Study S9916
Pauler, Donna K., Taplin, Mary Ellen, Burch, Patrick A. , Greene, Graham, Lara, Primo N. , Petrylak, Daniel P. , Crawford, Emily D. , Tangen, Catherine M. , Hussain, Maha , Small, Eric J. , Greene, G. F.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4505-4505
